iRay Group (SHA:688301)
China
· Delayed Price · Currency is CNY 121.00
+6.60 (5.77%)
Apr 1, 2025, 2:45 PM CST
iRay Group Market Cap
iRay Group has a market cap or net worth of 17.25 billion as of April 1, 2025. Its market cap has decreased by -28.19% in one year.
Market Cap
17.25B
Enterprise Value
18.58B
Revenue
1.86B
Ranking
n/a
PE Ratio
34.40
Stock Price
121.00
Market Cap Chart
Since September 18, 2020, iRay Group's market cap has increased from 11.61B to 17.25B, an increase of 48.54%. That is a compound annual growth rate of 9.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2025 | 17.25B | 26.34% |
| Dec 31, 2024 | 13.66B | -58.82% |
| Dec 29, 2023 | 33.16B | -0.38% |
| Dec 30, 2022 | 33.28B | -7.67% |
| Dec 31, 2021 | 36.05B | 189.42% |
| Dec 31, 2020 | 12.46B | 7.24% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 329.37B |
| Shenzhen Mindray Bio-Medical Electronics | 286.21B |
| WuXi AppTec | 193.34B |
| Aier Eye Hospital Group | 124.02B |
| Zhangzhou Pientzehuang Pharmaceutical., | 123.08B |
| Shanghai United Imaging Healthcare | 104.15B |
| Yunnan Baiyao Group Co.,Ltd | 101.83B |
| Sichuan Biokin Pharmaceutical | 93.16B |